Carpal tunnel syndrome: the median nerve in a passage that cannot expand
The tell is which fingers. The median nerve serves your thumb, index finger, middle finger, and the thumb-side half of your ring finger — and nothing else. If your little finger is numb too, the problem is probably not at the carpal tunnel, because that finger is fed by a different nerve entirely. Split your ring finger down the middle in your imagination: numbness on the thumb side and normal sensation on the little-finger side is close to a signature.
The second tell is the clock. This wakes people at two in the morning, and they shake the hand over the side of the bed until it settles. Wrists drift into a bent position during sleep, which is the position that squeezes the tunnel hardest.
What is happening is mechanical. The median nerve runs through a passage in the wrist floored by bone and roofed by a stiff ligament. The passage cannot expand. Anything that takes up room inside it — thickened tendon sheaths, fluid, swelling — presses the nerve against the roof.
The question everyone asks, and the trial that finally answered it
For years the honest answer to "surgery or an injection?" was that nobody knew. The Cochrane review published in 2024 looked at what existed and could not separate them: for clinical improvement beyond three months, its verdict on surgery versus corticosteroid injection was very low certainty.
Then a trial large enough to settle it reported. DISTRICTS randomised 934 people across 31 hospitals in the Netherlands to start with surgery or start with an injection, and followed them for eighteen months.
At eighteen months, 61% of the surgery group had recovered against 45% of the injection group.
That is a real difference and it points one way. Note the framing, though — the trial compared starting with one or the other, and people in either arm could go on to have more treatment. It is a comparison of opening moves, not of a permanent fork.
What splinting does, and the number that decides it
Against splinting, the Cochrane picture is more interesting than "surgery wins".
Surgery produced a higher rate of clinical improvement, on moderate-certainty evidence. But on the actual symptom and function scores, the difference between surgery and a splint did not reach the level considered clinically important. In other words, more people in the surgery group crossed the line marked "improved", while the average person's symptoms and hand function were not meaningfully further apart.
The number that resolves the tension is this one: 44 of every 100 people in the splinting groups ended up referred for surgery anyway.
So splinting is not a lesser version of surgery. It is a filter. Just over half the people who try it do not go on to need an operation, and the other 44% arrive at surgery later than they would have — having avoided nothing except time.
The cost side is real too. Adverse effects were reported in 61% of the surgery participants and 41% of the splinting participants, though the review is explicit that it is uncertain about this comparison.
If you are going to splint, splint the right joints
The standard wrist splint may not be the best version of the idea. A randomised trial compared the usual wrist-only splint against one that also holds the knuckles. The splint including the knuckles did better, and the advantage was still there six months later.
It also produced better pinch strength, which is the function people actually miss — opening packets, holding a key, doing up buttons.
The honest decision framework, written by people with no product to sell
The Cochrane authors did something unusual and wrote down who each route suits. It is worth reading as written, because it does not pretend the evidence picks for you.
Read against DISTRICTS, the two fit together. If your symptoms are severe and you want the highest chance of being recovered in a year and a half, starting with surgery is the better opening move. If your symptoms are tolerable and you have not tried anything yet, starting conservatively costs you a 44% chance of arriving at surgery later — and buys a better-than-even chance of never needing it.
What an updated review adds, and what it takes away
A 2026 systematic review reached the same shape of conclusion — durable recovery from surgery, short-term relief from injections and nerve stimulation — and then said something that belongs on this page more than its conclusion does.
Limited trials, and most of them at risk of bias. That is the state of the field outside of DISTRICTS, and it is why one large well-run trial changed the answer so much.
Get the diagnosis confirmed before you choose anything
DISTRICTS did not enrol people on symptoms alone: every participant had the diagnosis confirmed by nerve testing or ultrasound. That matters when you are deciding whether its 61% applies to you, because several conditions imitate this one — a nerve pinched in the neck, a more general nerve problem, arthritis at the base of the thumb. If the little finger is involved, or both hands and both feet are involved, the tunnel is probably not the whole story.
Ten people with carpal tunnel syndrome
Ten people have confirmed carpal tunnel syndrome and start with a corticosteroid injection. At eighteen months, between four and five of them are recovered. Ten others start with surgery: about six are recovered. Of ten who start with a splint, four to five end up referred for surgery anyway, and the rest do not. More of the operated group report an adverse effect, and the review is candid that it is not certain by how much.
Nobody can tell you in advance which of those you would have been. What the numbers do is set the price of waiting: it is not zero, and it is not disastrous.
The volume problem no compound addresses
No repair peptide has randomised human trial evidence in carpal tunnel syndrome. There is no result to summarise. This is a compression problem in a passage that cannot expand — the constraint is architectural, and any argument that a compound helps has to explain how it changes the volume inside a fixed tunnel. That argument, where it exists at all, belongs on a page naming both the compound and this condition, with its evidence tier attached. The operator of this site has a commercial interest in compounds of that kind, which is why this page states the absence rather than building a case.
Choosing your opening move
- Check the fingers. Thumb, index, middle, and the thumb side of the ring finger. Little finger involvement points somewhere else.
- Get it confirmed by nerve testing or ultrasound. The good evidence comes from trials that only enrolled confirmed cases.
- If you splint, use one that includes the knuckles. It beat the wrist-only splint and the advantage lasted six months.
- Know the price of starting conservatively. Roughly 44 in 100 end up referred for surgery anyway. That is the cost of the option, and for most people it is worth paying.
- If your symptoms are severe and you want the best odds at eighteen months, start with surgery. 61% against 45% in the largest trial available.
- Fix the night position. The bent wrist during sleep is what wakes you, and a splint worn only at night addresses the specific thing that is happening.
Ask this article · 2 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.